Table 1. Serum Levels of sCD30 in HD at... | American Society of Hematology

Table 1.

Serum Levels of sCD30 in HD at Diagnosis According to Presentation Features

Feature	No. of Patients	sCD30 U/mL			P^*
Feature	No. of Patients	Mean ± SEM	Median	Range	P^*
Controls	113	5.3 ± 0.53	4	0-20
All cases	303	94 ± 7	45	1-815	<.001
Males	151	94 ± 11	43	2-815
Females	152	91 ± 9	47	1-612	.668
Age ≥50 yr	51	135 ± 23	68	4-815
Age <50 yr	252	86 ± 7	43	1-712	.01
Stage I-II	202	69 ± 7	37	1-609
Stage III-IV	101	145 ± 16	93	2-815	<.001
Stage A	167	62 ± 7	33	2-609
Stage B	136	133 ± 13	66	1-815	<.001
Bulky	85	135 ± 15	77	2-666
Nonbulky	218	78 ± 8	37	1-815	<.001
NS	210	92 ± 8	44	1-712
MC	53	105 ± 19	64	6-815	.028
LP	21	55 ± 14	35	6-277
LD	6	309 ± 102	297	29-666

Feature	No. of Patients	sCD30 U/mL			P^*
Feature	No. of Patients	Mean ± SEM	Median	Range	P^*
Controls	113	5.3 ± 0.53	4	0-20
All cases	303	94 ± 7	45	1-815	<.001
Males	151	94 ± 11	43	2-815
Females	152	91 ± 9	47	1-612	.668
Age ≥50 yr	51	135 ± 23	68	4-815
Age <50 yr	252	86 ± 7	43	1-712	.01
Stage I-II	202	69 ± 7	37	1-609
Stage III-IV	101	145 ± 16	93	2-815	<.001
Stage A	167	62 ± 7	33	2-609
Stage B	136	133 ± 13	66	1-815	<.001
Bulky	85	135 ± 15	77	2-666
Nonbulky	218	78 ± 8	37	1-815	<.001
NS	210	92 ± 8	44	1-712
MC	53	105 ± 19	64	6-815	.028
LP	21	55 ± 14	35	6-277
LD	6	309 ± 102	297	29-666

*P value refers to Mann-Whitney U and Kruskal-Wallis tests.